[PDF][PDF] Oral anticoagulant discontinuation in patients with nonvalvular atrial fibrillation
S Kachroo, M Hamilton, X Liu, X Pan, D Brixner… - Am J Manag …, 2016 - academia.edu
… management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management
of atrial fibrillation. … Dabigatran etexilate: the first oral anticoagulant available in the United …
of atrial fibrillation. … Dabigatran etexilate: the first oral anticoagulant available in the United …
Prevention and treatment of venous thromboembolism and pulmonary embolism: the role of novel oral anticoagulants
S Deftereos, G Hatzis, C Kossyvakis… - Current Clinical …, 2012 - ingentaconnect.com
… and treatment of VTE, prevention of stroke and other embolic disorders correlated with atrial
fibrillation) led to … Economic evaluation of dabigatran etexilate for the prevention of venous …
fibrillation) led to … Economic evaluation of dabigatran etexilate for the prevention of venous …
Dabigatran: the anticoagulant we have long expected?
GI Tagarakis, D Karangelis… - Recent Patents on …, 2010 - ingentaconnect.com
… the evaluation of dabigatran in patients with atrial fibrillation [… Economic evaluation of
dabigatran etexilate for the prevention of … Economic evaluation of dabigatran etexilate for the …
dabigatran etexilate for the prevention of … Economic evaluation of dabigatran etexilate for the …
Analysis of the projected utility of dabigatran, rivaroxaban, and apixaban and their future impact on existing Hematology and Cardiology Anticoagulation Clinics at The …
KL Carter, MB Streiff, PA Ross, JC Wellman… - Journal of thrombosis …, 2012 - Springer
… Dabigatran, rivaroxaban, and apixaban are all being investigated for a broad range of …
including management of atrial fibrillation, acute coronary syndromes, and the treatment and …
including management of atrial fibrillation, acute coronary syndromes, and the treatment and …
Efficacy and safety of rivaroxaban in real-life patients with atrial fibrillation
G Barón-Esquivias, F Fernandez-Aviles… - Expert review of …, 2015 - Taylor & Francis
… ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC
Guidelines for the management of atrial fibrillation. Developed with the special contribution of the …
Guidelines for the management of atrial fibrillation. Developed with the special contribution of the …
PCV139 Epidemiology and Economic Burden of Atrial Fibrilation to the Public Health Care System in Brazil
V Nasciben, LSP Piegas, M Figueiredo… - Value in …, 2011 - valueinhealthjournal.com
… data on atrial fibrillation (AF) and perform a cost analysis of … OBJECTIVES: To describe current
management of acute … ) over 12 months in Greece. METHODS: Prospective observational …
management of acute … ) over 12 months in Greece. METHODS: Prospective observational …
[PDF][PDF] 2012 focused update of the ESC Guidelines for the management of atrial fibrillation
GYHL UK, R De Caterina, IS UK, D Atar… - European Heart …, 2012 - cardiacos.net
… Evaluation … Long-term anticoagulant therapY with dabigatran etexilate ROCKET-AF …
Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in atrial fibrillation …
Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in atrial fibrillation …
[HTML][HTML] WatchBP Home A for opportunistically detecting atrial fibrillation during diagnosis and monitoring of hypertension: a NICE Medical Technology Guidance
I Willits, K Keltie, J Craig, A Sims - … health economics and health policy, 2014 - Springer
… of the WatchBP Home A as well as to support the assumptions of the economic analysis. …
recruited from secondary care in the USA and Greece, lending them susceptible to referral and …
recruited from secondary care in the USA and Greece, lending them susceptible to referral and …
… /AIAC/SICI-GISE/SIC/SICCH consensus document: percutaneous occlusion of the left atrial appendage in non-valvular atrial fibrillation patients: indications, patient …
G Casu, MM Gulizia, G Molon… - European Heart …, 2017 - academic.oup.com
… treatment of AF is the prevention of thromboembolic complications with oral anticoagulation
therapy. Drug treatment … have been introduced (dabigatran etexilate, rivaroxaban, apixaban, …
therapy. Drug treatment … have been introduced (dabigatran etexilate, rivaroxaban, apixaban, …
[HTML][HTML] Rivaroxaban: expanded role in cardiovascular disease management—a literature review
M Ajmal, J Friedman, QUAR Sipra… - Cardiovascular …, 2021 - hindawi.com
… In Greece, rivaroxaban was also cost-effective in the … In the treatment of PAD when
clinic-economic analysis of rivarox… ban and the thrombin inhibitor dabigatran etexilate in patients …
clinic-economic analysis of rivarox… ban and the thrombin inhibitor dabigatran etexilate in patients …